Amanta Healthcare files DRHP with SEBI

05 Oct 2024 Evaluate

Amanta Healthcare has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI). The issue size will be up to 1,25,00,000 equity shares with face value of Rs 10 each. 

The company propose to utilize Rs 7,000 lakh of its net proceeds for funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat and Rs 3,000 lakh for funding capital expenditure requirements towards purchase of equipment, plant and machinery for setting up new line for SVP at Hariyala, Kheda, Gujarat.

Amanta Healthcare, located in Ahmedabad (Gujarat) has emerged as India’s most versatile manufacturer and marketer of sterile dosages in Aseptic Blow -- Fill -- Seal (BFS) and Injection Stretch Blow Moulding (ISBM) space with well integrated operations -- F & D to full scale manufacturing & capability to develop customized solutions (containers, closures & drug delivery).

Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.